SCHEMBL8237166

SCHEMBL8237166

CC(=O)CC1CCN(Cc2c(Cl)cccc2Cl)CC1

nearest known ligand 0.56

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CXCR4 P61073 7/20 0.56
KDM4E B2RXH2 4/20 0.51
POLB P06746 1/20 0.51
TSHR P16473 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
ALDH1A1 P00352 5/20 0.49
TDP1 Q9NUW8 2/20 0.49
CYP2A13 Q16696 1/20 0.49
SIGMAR1 Q99720 1/20 0.48
MEN1 O00255 1/20 0.46
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
KMT2A Q03164 1/20 0.46
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
ALOX15 P16050 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2445773 0.87 CXCR4 (0.54) CXCR4KDM4EPOLBTSHRSMN1; SMN2
SCHEMBL15338728 0.86 CXCR4 (0.53) CXCR4KDM4EPOLBTSHRSMN1; SMN2
SCHEMBL12401142 0.85 CXCR4 (0.53) CXCR4KDM4EPOLBTSHRSMN1; SMN2
SCHEMBL14943352 0.84 SCN4A (0.44) CXCR4KDM4EALDH1A1MEN1KMT2A
SCHEMBL4505679 0.81 ACHE (0.63) CXCR4
SCHEMBL19084133 0.80 CYP2A13 (0.56) CXCR4KDM4EPOLBTSHRSMN1; SMN2
SCHEMBL19083687 0.77 ACHE (0.61) CXCR4KDM4EPOLBTSHRSMN1; SMN2
SCHEMBL28551278 0.76 CYP2A13 (0.54) CXCR4KDM4EPOLBTSHRSMN1; SMN2
SCHEMBL6944902 0.73 CYP2A13 (0.59) CXCR4KDM4EPOLBTSHRSMN1; SMN2
SCHEMBL19075616 0.73 CYP2A13 (0.54) CXCR4KDM4EPOLBTSHRSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2366704-B1 Inhibitors of serine proteases VERTEX PHARMA (US) 2013-10-23 EP disclosed
EP-2631238-A1 Spirocyclic inhibitors of serine proteases for the treatment of hcv infections VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-08-28 EP disclosed
EP-2366704-A1 Inhibitors of serine proteases VERTEX PHARMACEUTICALS INCORPORATED (US) 2011-09-21 EP disclosed
WO-2007025307-A2 INHIBITORS OF SERINE PROTEASES VERTEX PHARMACEUTICALS INCORPORATED (US) 2007-03-01 WO disclosed